Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001213900-24-090768
Filing Date
2024-10-25
Accepted
2024-10-25 16:01:19
Documents
3
Group Members
AMALAR HOLDING S.R.O.PPF BIOTECH B.V.RENATA KELLNEROVA

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 10 TO SCHEDULE 13D ea0218619-13da10ppf_autolus.htm SC 13D/A 89054
2 JOINT FILING AGREEMENT, DATED AS OF OCTOBER 25, 2024 ea021861902ex99-1_autolus.htm EX-99.1 9652
3 POWER OF ATTORNEY OF AMALAR HOLDING S.R.O., DATED AS OF AUGUST 5, 2024 ea021861902ex99-3_autolus.htm EX-99.3 8893
  Complete submission text file 0001213900-24-090768.txt   109352
Mailing Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP
Business Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP 44 20 3829 6230
Autolus Therapeutics plc (Subject) CIK: 0001730463 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90550 | Film No.: 241397031
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address STRAWINSKYLAAN 933 AMSTERDAM P7 1077XX
Business Address STRAWINSKYLAAN 933 AMSTERDAM P7 1077XX 31(0) 20 8813120
PPF Group N.V. (Filed by) CIK: 0001788137 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7
Type: SC 13D/A